22nd Century Price to Book Ratio 2011-2024 | XXII
Historical price to book ratio values for 22nd Century (XXII) over the last 10 years. The current price to book ratio for 22nd Century as of November 04, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| 22nd Century Price/Book Ratio Historical Data |
| Date |
Stock Price |
Book Value per Share |
Price to Book Ratio |
| 2024-11-01 |
0.10 |
|
0.00 |
| 2024-06-30 |
0.75 |
$-0.10 |
-7.24 |
| 2024-03-31 |
1.92 |
$-3.23 |
-0.59 |
| 2023-12-31 |
2.98 |
$-3.09 |
-0.96 |
| 2023-09-30 |
15.64 |
$10.47 |
1.49 |
| 2023-06-30 |
91.85 |
$72.93 |
1.26 |
| 2023-03-31 |
184.56 |
$89.91 |
2.05 |
| 2022-12-31 |
220.92 |
$107.02 |
2.06 |
| 2022-09-30 |
222.55 |
$134.91 |
1.65 |
| 2022-06-30 |
511.20 |
$120.68 |
4.24 |
| 2022-03-31 |
556.80 |
$84.51 |
6.59 |
| 2021-12-31 |
741.60 |
$97.31 |
7.62 |
| 2021-09-30 |
710.40 |
$116.47 |
6.10 |
| 2021-06-30 |
1111.20 |
$128.82 |
8.63 |
| 2021-03-31 |
789.60 |
$82.62 |
9.56 |
| 2020-12-31 |
528.00 |
$76.09 |
6.94 |
| 2020-09-30 |
153.79 |
$86.44 |
1.78 |
| 2020-06-30 |
183.46 |
$93.06 |
1.97 |
| 2020-03-31 |
180.00 |
$100.73 |
1.79 |
| 2019-12-31 |
264.00 |
$107.58 |
2.45 |
| 2019-09-30 |
542.40 |
$105.49 |
5.14 |
| 2019-06-30 |
501.60 |
$119.89 |
4.18 |
| 2019-03-31 |
410.40 |
$134.35 |
3.05 |
| 2018-12-31 |
597.60 |
$137.18 |
4.36 |
| 2018-09-30 |
674.40 |
$153.29 |
4.40 |
| 2018-06-30 |
590.40 |
$139.92 |
4.22 |
| 2018-03-31 |
564.00 |
$149.73 |
3.77 |
| 2017-12-31 |
672.00 |
$146.42 |
4.59 |
| 2017-09-30 |
664.80 |
$65.29 |
10.18 |
| 2017-06-30 |
420.00 |
$61.55 |
6.82 |
| 2017-03-31 |
283.20 |
$57.81 |
4.90 |
| 2016-12-31 |
261.60 |
$64.36 |
4.06 |
| 2016-09-30 |
348.00 |
$47.19 |
7.37 |
| 2016-06-30 |
194.90 |
$44.05 |
4.42 |
| 2016-03-31 |
187.92 |
$52.52 |
3.58 |
| 2015-12-31 |
336.00 |
$39.62 |
8.48 |
| 2015-09-30 |
201.60 |
$48.12 |
4.19 |
| 2015-06-30 |
225.60 |
$56.15 |
4.02 |
| 2015-03-31 |
206.40 |
$44.35 |
4.65 |
| 2014-12-31 |
396.00 |
$56.97 |
6.95 |
| 2014-09-30 |
604.80 |
$75.35 |
8.03 |
| 2014-06-30 |
736.80 |
$36.92 |
19.96 |
| 2014-03-31 |
780.00 |
$41.83 |
18.65 |
| 2013-12-31 |
513.60 |
$31.71 |
16.19 |
| 2013-09-30 |
309.60 |
$-83.16 |
-3.72 |
| 2013-06-30 |
170.40 |
$-38.97 |
-4.37 |
| 2013-03-31 |
211.20 |
$-49.19 |
-4.29 |
| 2012-12-31 |
180.00 |
$-42.90 |
-4.20 |
| 2012-09-30 |
67.20 |
$-18.22 |
-3.69 |
| 2012-06-30 |
84.00 |
$-15.49 |
-5.42 |
| 2012-03-31 |
148.80 |
$-24.50 |
-6.07 |
| 2011-12-31 |
100.80 |
$-10.69 |
-9.43 |
| 2011-09-30 |
144.00 |
|
0.00 |
| 2011-06-30 |
276.00 |
|
0.00 |
| 2011-03-31 |
288.00 |
|
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Consumer Staples |
Tobacco Products |
$0.003B |
$0.032B |
|
22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York.
|
